Literature DB >> 17881926

Prevalence and axial length of hiatus hernia in patients, with nonerosive reflux disease: a prospective study.

Spiros N Sgouros1, Dimitrios Mpakos, Miltiadis Rodias, Kostas Vassiliades, Christos Karakoidas, Evangelos Andrikopoulos, Gerasimos Stefanidis, Apostolos Mantides.   

Abstract

BACKGROUND AND AIMS: The relationship between hiatus hernia and reflux esophagitis is well established. However, there are conflicting reports regarding its effect on the development of nonerosive reflux disease (NERD). Our aim was to investigate the prevalence and axial length of hiatus hernia in patients with NERD, compared with patients with reflux esophagitis, Barrett esophagus, and controls.
METHODS: Axial hernia length of the diaphragmatic hiatus was measured prospectively at endoscopy in controls and patients with typical reflux symptoms occurring at least weekly during the last month relieved by antacids.
RESULTS: A final diagnosis of hiatus hernia was established in 21.2% of 249 controls, 60.4% of 346 patients with NERD, 78.1% of 251 patients with reflux esophagitis, and 88.2% of 17 patients with Barrett esophagus. Patients aged >59 years were most likely to have a hiatus hernia. There was an increased prevalence in patients with NERD as compared with controls (P<0.0001), and decreased prevalence as compared with those with reflux esophagitis and Barrett esophagus (P<0.0001 and 0.02, respectively). Axial length of hiatus hernia >3 cm was found more frequently in patients with reflux esophagitis and Barrett esophagus as compared with patients with NERD (P<0.0001 and 0.0052, respectively). There was no statistical significant difference between controls and patients with NERD regarding the prevalence of hiatus hernia >3 cm (P=0.0904).
CONCLUSIONS: A small (<3 cm) hiatus hernia may contribute to the development of NERD, whereas an axial length >3 cm is associated with a more severe disease.

Entities:  

Mesh:

Year:  2007        PMID: 17881926     DOI: 10.1097/01.mcg.0000225678.99346.65

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  7 in total

1.  Medium-term durability of giant hiatus hernia repair without mesh.

Authors:  R V Furtado; S J Vivian; H van der Wall; G L Falk
Journal:  Ann R Coll Surg Engl       Date:  2016-07-07       Impact factor: 1.891

2.  The Hill's Classification Is Useful to Predict the Development of Postoperative Gastroesophageal Reflux Disease and Erosive Esophagitis After Laparoscopic Sleeve Gastrectomy.

Authors:  Koy Min Chue; Daniel Wen Xiang Goh; Cheryl Min En Chua; Bin Chet Toh; Lester Wei Lin Ong; Wai Keong Wong; Chin Hong Lim; Jeremy Tian Hui Tan; Baldwin Po Man Yeung
Journal:  J Gastrointest Surg       Date:  2022-06       Impact factor: 3.267

Review 3.  Nonerosive reflux disease: a pathophysiologic perspective.

Authors:  John D Long; Roy C Orlando
Journal:  Curr Gastroenterol Rep       Date:  2008-06

4.  Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.

Authors:  I M Modlin; R H Hunt; P Malfertheiner; P Moayyedi; E M Quigley; G N J Tytgat; J Tack; R C Heading; G Holtman; S F Moss
Journal:  Digestion       Date:  2009-06-17       Impact factor: 3.216

5.  Evaluation of gastroesophageal reflux disease and hiatal hernia as risk factors for lobectomy complications.

Authors:  Michael F Kaminski; Theresa Ermer; Maureen Canavan; Andrew X Li; Richard C Maduka; Peter Zhan; Daniel J Boffa; Meaghan Dendy Case
Journal:  JTCVS Open       Date:  2022-06-03

6.  Hill classification is superior to the axial length of a hiatal hernia for assessment of the mechanical anti-reflux barrier at the gastroesophageal junction.

Authors:  Ida Hansdotter; Ove Björ; Anna Andreasson; Lars Agreus; Per Hellström; Anna Forsberg; Nicholas J Talley; Michael Vieth; Bengt Wallner
Journal:  Endosc Int Open       Date:  2016-02-10

7.  Stretta procedure versus proton pump inhibitors for the treatment of nonerosive reflux disease: A 6-month follow-up.

Authors:  Suyu He; Fei Xu; Xin Xiong; Hui Wang; Lipeng Cao; Ninglin Liang; Hanmei Wang; Xiaojuan Jing; Tianyu Liu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.